Areas critical to watch include pharma class actions, the growth of collective redress outside of the U.S., mounting litigation around “forever chemicals,” and artificial intelligence (AI), writes Insurance Journal's Jahna Jacobson.
Areas critical to watch include pharma class actions, the growth of collective redress outside of the U.S., mounting litigation around “forever chemicals,” and artificial intelligence (AI), writes Insurance Journal's Jahna Jacobson.
